Skip to main content
Menu
US

ctdna Workflows

Biomarkers in cell-free fluids

At Revvity, we specialize in advanced ctDNA (circulating tumor DNA) workflows that cater to your needs in non-invasive cancer and biomarker research. Our solutions are designed to streamline and enhance the precision of ctDNA analysis, helping you achieve reliable and actionable insights.
 

For research use only. Not for use in diagnostic procedures.

ctdna Workflows

Comprehensive liquid biopsy solutions

Sample preparation

Our workflows begin with meticulous sample preparation realized a reliable plasma fractionation with the JANUS™ G3 Blood iQ™ workstation. The proprietary technology allows precise identification and separation of the plasma and buffy coat layers in centrifuged blood tubes enabling increased efficiency, reduced errors, and improved traceability of your samples.

Suggested products:

We use optimized protocols to ensure high integrity extraction of ctDNA from cell-free fluids, minimizing contamination to deliver accurate results. The chemagic™ technology allows comparable yields to manual spin column methods with efficient removal of contaminants and no detectable cross-contamination while reducing variability and preserving sample integrity with full tracking capabilities.

Quality control

Quality control in circulating tumor DNA analysis is crucial for ensuring accurate and reliable results, which are essential for effective genomic profiling in cancer research. The LabChip® GX Touch™ HT Nucleic Acid Analyzer and LabChip™ cfDNA assay is optimized to assess fragment distribution and quantitation of extracted cfDNA samples.

Suggested products:

 

Library prep

We employ cutting-edge technologies to allow for comprehensive genetic profiling with an accelerated workflow and minimal hands-on time. Use as little as 10 ng of input cfDNA for your library preparation using the NEXTFLEX™ Cell Free DNA-Seq Kit 2.0.

Suggested products:

Verify your oncology workflows with our cell line-derived Mimix™ Cell-Free DNA reference standard for patient-like performance. Containing fragmented DNA to mimic ctDNA with genetically defined common cancer mutations providing reliable controls for liquid biopsy assays.

By incorporating unique dual indexes (UDI) into our adapters, Revvity ensures that each sample is uniquely identified during sequencing, which helps prevent index hopping and cross-contamination. We also offer adapters with both unique molecular identifiers (UMI). UMIs are used to track individual DNA or RNA molecules throughout the sequencing process. This is especially useful for improving data accuracy. Both NEXTFLEX UDI-UMI and UDI barcodes facilitate high-throughput multiplexing, reduction of false positive calls and rare variant detection.

Globin transcripts constitute a significant portion of the total mRNA in whole blood or blood-derived samples such as plasma. This can compromise the detection of low-abundance transcripts. The DepleteX™ Globin Depletion Kit selectively removes highly expressed globin transcripts (HBA1, HBA2, HBB, & HBD) in vitro before sequencing. This process redirects sequencing resources toward unique biologically relevant transcripts, maximizing UMI and gene sensitivity.

Why choose Revvity?

  • Expertise: Our team of experts brings extensive experience in cfDNA workflows, ensuring that each step is executed with precision.
  • Innovation: We leverage the latest advancements in technology to provide you with the most advanced solutions available.
  • Customization: We understand that every research project is unique. Our workflows can be tailored to meet your specific needs and goals.

Contact us

To learn more about how our ctDNA workflows can enhance your research, please check the additional resources below. We are here to provide you with detailed information and support tailored to your needs. Contact us to discuss and realize your entire ctDNA workflow.

Questions?
We’re here to help.

Contact us